Toxin-antitoxin (TA) systems are small genetic elements that are widely prevalent in the genomes of bacteria and archaea. These modules have been identified in various bacteria and proposed to play an important role in bacterial physiology and virulence. However, their presence in the genomes of Actinobacillus species has received no attention. In this study, we describe the identification of four type II TA systems in Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia. Reverse transcription PCR analysis revealed that the genes encoding the toxin and antitoxin are co-transcribed. Overexpression of each toxin inhibited the growth of Escherichia coli, and the toxic effect could be counteracted by its cognate antitoxin. The pull-down experiments demonstrated that each toxin interacts with its cognate antitoxin in vivo. The promoter activity assays showed that each antitoxin could autoregulate either positively or negatively the TA operon transcription. In addition, the APJL 0660/0659 TA system is present in half of the detected serovars of A. pleuropneumoniae, while the others are present in all. Collectively, we identified four type II TA systems in A. pleuropneumoniae, and this study has laid the foundation for further functional study of these TA systems.
INTRODUCTION
Toxin-antitoxin (TA) systems are small genetic elements comprising antitoxin and toxin genes (Yamaguchi, Park and Inouye 2011; Fernandez-Garcia et al. 2016; Kedzierska and Hayes 2016) . They were initially identified on low copy number plasmids where they function as plasmid maintenance systems (Gerdes, Rasmussen and Molin 1986) , and have been subsequently characterized in various bacteria and archaea (Lee and Lee 2016) . Currently, six types of TA systems (types I to VI) have been described based on the nature and mode of action of the antitoxin (Kedzierska and Hayes 2016) . In the type I and III TA systems, the antitoxin is a small non-coding RNA, which either binds to the toxin mRNA and inhibits the production of toxin (type I) or interacts directly with the toxin and neutralizes its toxicity (type III) (Yamaguchi, Park and Inouye 2011) . Type II TA system is the best studied type of TA modules, in which the toxin and antitoxin are both proteins. The antitoxin blocks the toxicity of toxin by forming a complex with it (Yamaguchi, Park and Inouye 2011) . In the type IV and V TA systems, the protein antitoxin either binds directly to the targets of the toxin, thus protecting them (type IV) (Masuda et al. 2012) , or inhibits the toxin by cleaving specifically its mRNA (type V) (Wang et al. 2012) . Type VI TA system is the most recently identified type of TA modules, in which the antitoxin is a proteolytic adaptor that is required for toxin degradation by the protease ClpXP (Aakre et al. 2013) .
Among these TA systems, the type II TA systems have been the most extensively studied (Yamaguchi, Park and Inouye 2011) , possibly due to their abundance in prokaryotes and the development of web-based tools for identifying them (Sevin and BarloyHubler 2007; Shao et al. 2011) . Through bioinformatics analysis and experiment verification, a large number of type II TA modules have been identified over the past years, such as the HicA3-HicB3 TA system in Yersinia pestis (Bibi-Triki et al. 2014) , the yefM-yoeB locus in Streptococcus suis (Zheng et al. 2015) , the HicAB TA system in Pseudomonas aeruginosa (Li et al. 2016a) , the VapC/VapB TA system in Streptomyces sp. (Guo et al. 2016 ) and the relBE locus in Streptomyces Cattleya (Li et al. 2016b) . The type II TA systems play an important role in intracellular processes, including mRNA translation, DNA replication, cell wall and cell membrane synthesis, and cell division (Kedzierska and Hayes 2016) . Moreover, there are increasing evidences that some type II TA systems contribute to bacterial pathogenesis (Kedzierska and Hayes 2016; Lobato-Marquez, Diaz-Orejas and Garcia-Del Portillo 2016) . For example, a type II TA module, referred to as sehAB, promotes virulence of Salmonella Typhimurium (De la Cruz et al. 2013) . Therefore, it is necessary to characterize novel type II TA systems in pathogenic bacteria.
Actinobacillus pleuropneumoniae is a Gram-negative bacterium and causes porcine pleuropneumonia which leads to severe economic losses in the swine industry worldwide (Chiers et al. 2010) . Based on the requirement for nicotinamide adenine dinucleotide (NAD), A. pleuropneumoniae strains could be classified into biotype I (NAD dependent) and biotype II (NAD independent) (Dom and Haesebrouck 1992) . Furthermore, 16 serovars of A. pleuropneumoniae have been proposed on the basis of capsular polysaccharide structure (Sarkozi, Makrai and Fodor 2015; Bosse et al. 2017) . The pathogenesis of A. pleuropneumoniae infection, involving different virulence factors of this pathogen, has been partly elucidated (Chiers et al. 2010) . Various factors have been proved to contribute to the infection process, such as the RNA chaperone Hfq (Subashchandrabose et al. 2013) , the two-component system QseB/QseC (Liu et al. 2015) and the Adh adhesin (Wang et al. 2015 . However, the presence of TA systems in A. pleuropneumoniae has not been reported yet. By bioinformatics analysis, several potential type II TA loci have been predicted in the genome of A. pleuropneumoniae serovar 3 str. JL03. The purpose of this study was to determine whether these loci function as active type II TA systems.
MATERIALS AND METHODS

Bacterial strains, plasmids, primers and growth conditions
Bacterial strains and plasmids used in this study are listed in Supplementary 
RNA isolation and RT-PCR analysis
Actinobacillus pleuropneumoniae serovar 3 str. JL03 was grown to mid-exponential phase and total RNA was purified using an SV total RNA isolation system (Promega), according to the manufacturer's protocol. RNA integrity and concentrations were determined by agarose gel electrophoresis and NanoDrop, respectively. The cDNAs were generated from these RNA samples with HiScript II Q RT SuperMix (Vazyme, Nanjing, China). For the cotranscription assay, the gene specific primers (Supplementary  Table S2 ) were used for PCR amplification.
Construction of plasmids
The APJL 0659 gene was amplified from the genome of A. pleuropneumoniae serovar 3 str. JL03 using primer pair 0659F/0659R. After digestion with the EcoR I and Hind III enzymes, the fragment was ligated into pBADhisA, to generate pBADhisA-0659. The pBADhisA-1219, -1288, -1376, -1757, -1767 and -1864 plasmids were constructed in a similar manner using primer pairs 1219F/1219R, 1288F/1288R, 1376F/1376R, 1757F/1757R, 1767F/1767R and 1864F/1864R, respectively. The APJL 0660/0659 locus was amplified from the genome of A. pleuropneumoniae serovar 3 str. JL03 using primer pair 0660F/0659R. The DNA fragment was digested with the Kpn I and Hind III enzymes, and then cloned into pBADhisA, to yield pBADhisA-0660-0659. The pBADhisA-1220-1219, -1287-1288, -1766-1767 and -1865-1864 plasmids were constructed in a similar manner using primer pairs 1220F/1219R, 1287F/1288R, 1766F/1767R and 1865F/1864R, respectively.
The pHGEI01-based plasmids for the APJL 0660/0659 locus were constructed as previously described (Guo et al. 2016 ) using pHGEI01-P0660-0659-F as the forward primer, pHGEI01-0660'-R1, pHGEI01-0659'-R1 and pHGEI01-0660-0659-R1 as the reverse primers, respectively, for the first-step PCR, and then a sequence containing the ribosome-binding site was added by the second-step PCR using primer pair pHGEI01-P0660-0659-F/pHGEI01-common-R2. The PCR products were digested with the EcoR I and BamH I enzymes, and then cloned into pHGEI01, to generate pHGEI01-0660 , pHGEI01-0660-0659 and pHGEI01-0660-0659, respectively. The pHGEI01-based plasmids for the other TA loci were constructed using the same procedure.
Escherichia coli growth assays
Escherichia coli Top10 cells transformed with pBADhisA-based plasmids or pBADhisA (control) were grown in LB broth with 75 μg/mL ampicillin and 0.2% D-glucose at 37
• C overnight. The next day, the cultures were diluted 1:100 in LB-ampicillin and grown to an OD 600 of 0.05-0.25 when each culture was divided into two parts. One half was grown in the presence of 0.2% D-glucose (repression conditions), while the other in the presence of 0.2% L-arabinose (induction conditions). Culture growth was monitored by measuring the OD 600 every hour.
For the cell viability assay, overnight cultures of E. coli Top10 carrying pBADhisA-toxin plasmids or pBADhisA (control) were diluted 1:100 in LB-ampicillin and grown to an OD 600 of 0.5-0.6. Each culture was then divided into two parts, supplemented with either 0.2% D-glucose or L-arabinose, and continued for 3 h. Aliquots were removed at hourly intervals and the numbers of CFU were determined by plating appropriate dilutions on LB ager containing 0.2% D-glucose.
Protein expression and purification
Escherichia coli Top10 cells harboring the respective pBADhisA-AT plasmids for each TA locus were grown to an OD 600 of 0.6, and induced by addition of 0.2% L-arabinose for 3 h. Cells were collected, resuspended in binding buffer (20 mM Na 3 PO 4 , 0.5 M NaCl, 30 mM imidazole, pH 7.4) and lysed with a cell disruptor. Co-purification of antitoxin-His 6 with toxin was performed using Ni-NTA resins (GE Healthcare) according to the manufacturer's protocol. The purified proteins were separated with 15% SDS-PAGE.
Promoter activity assays
Promoter activity assays were performed as previously described (Guo et al. 2016) . The pHGEI01-based plasmids were introduced into E. coli WM3064 strain. Cells grown to midexponential phase (OD 600 = 0.6) were collected, washed with PBS and resuspended in lysis buffer (0.25 M Tris/HCl, pH 7.5, 0.5% Trion-X100). After sonication, the soluble protein was collected and the protein concentration was measured using a bicinchoninic acid assay kit (Biosharp). The β-galactosidase activity was determined using a β-galactosidase assay kit (TIANDZ, Beijing, China) according to the manufacturer's instructions.
RESULTS
Identification of putative type II TA systems in Actinobacillus pleuropneumoniae
The putative TA modules in A. pleuropneumoniae serovar 3 str. JL03 were predicted with RASTA-Bacteria (Sevin and BarloyHubler 2007) , and 29 potential TA pairs scored above 70. These pairs were compared with the type II TA loci of A. pleuropneumoniae serovar 3 str. JL03 listed in the TADB database (Shao et al. 2011) . Seven modules simultaneously identified by the two tools were considered as putative type II TA systems and picked for further study: APJL 0660/0659 (TA1), APJL 1220/1219 (TA2), APJL 1287/1288 (TA3), APJL 1375/1376 (TA4), APJL 1756/1757 (TA5), APJL 1766/1767 (TA6) and APJL 1865/1864 (TA7).
Co-transcription analysis of putative type II TA systems
A genetic structure analysis revealed that each toxin gene is tightly linked to its cognate antitoxin gene (Fig. 1A) . For each putative TA module, the toxin and antitoxin genes are overlapped or separated by a few nucleotides (Fig. 1A) . Except for the putative TA4, each toxin gene is located downstream of its cognate antitoxin gene (Fig. 1A) . Results of RT-PCR analysis (Fig. 1B) indicated the expected sizes for each TA locus, all consistent with that of the genomic DNA (gDNA). However, no PCR products were detected in the negative controls (cDNA-) (Fig. 1B) , in which the reverse transcription was performed without reverse transcriptase. These results revealed that for each putative TA module, the toxin and antitoxin genes are co-transcribed, and form a bicistronic operon.
Assessment of the toxic effects of putative toxins on growth of Escherichia coli
When grown in the presence of 0.2% glucose (repression condition), Top10 cells harboring pBADhisA-1757 showed a moderate growth defect compared to that harboring pBADhisA, while cells harboring other pBADhisA-toxin plasmids displayed no major difference in growth (Fig. 2A) . In the case of induction conditions, Top10 cells containing pBADhisA-1376 exhibited a slight growth inhibition compared to that containing pBADhisA, whereas growth of cells containing other pBADhisA-toxin plasmids was severely impaired (Fig. 2B) . Induction of APJL 1376 only slightly attenuated E. coli growth, suggesting that APJL 1376 is either not a toxin or that its toxicity is limited in a heterologous expression system. Therefore, further research focused on the remaining six potential type II TA systems.
Following induction with 0.2% arabinose, a great reduction in the number of viable cells was observed for Top10 cells carrying pBADhisA-toxin plasmids, and the reduction in the number of CFU depended on the toxin tested ( Fig. 3A-F) . By contrast, the number of viable cells increased in the cultures supplemented with 0.2% D-glucose (Fig. 3A-F) . For Top10 cells carrying pBADhisA, the number of viable cells continued to increase under both induction and repression conditions (Fig. 3G) .
Taken together, these results indicated that the products of APJL 0659, APJL 1219, APJL 1288, APJL 1757, APJL 1767 and APJL 1864 have toxic effects on E. coli growth.
Evaluation of the antitoxic effects of putative antitoxins
To determine whether the toxic effect of each toxin can be alleviated by its cognate antitoxin, the entire sequence of each putative TA module was cloned into pBADhisA. Five of the six potential TA loci were successfully ligated into pBADhisA, and the resulting plasmids designated pBADhisA- 0660-0659, -1220-1219, -1287-1288, -1766-1767 and -1865-1864 , respectively. As seen in Fig. 4 , induction of APJL 0660/0659, APJL 1287/1288, APJL 1766/1767 and APJL 1865/1864 resulted in normal growth of Top10 cells, suggesting that the products of APJL 0660, APJL 1287, APJL 1766 and APJL 1865 have antitoxic effects. However, growth inhibition was observed for induction of APJL 1220/1219 (Fig. 4B) , revealing that APJL 1220 may not function as an antitoxin. Therefore, only the loci APJL 0660/0659, APJL 1287/1288, APJL 1766/1767 and APJL 1865/1864 work as typical type II TA systems.
Each toxin interacts with its cognate antitoxin in vivo
To examine the possible interaction between the toxin and its cognate antitoxin, pull-down experiments were performed with the respective pBADhisA-AT plasmids for each TA locus. Using these plasmids, the antitoxins were expressed as hexahistidine fusion proteins (His 6 -tagged) along with untagged toxins from the araBAD promoter. Escherichia coli Top10 cells harboring pBADhisA-0660-0659, -1287-1288, -1766-1767 or -1865-1864 were induced with 0.2% L-arabinose, and purified with Ni-NTA resins. Following elution of each protein sample, two distinct bands corresponding to the expected molecular masses of antitoxin-His 6 and toxin were observed on SDS-PAGE (Fig. 5) , suggesting that under native conditions, each toxin was successfully co-purified with its cognate antitoxin (His-tagged). These results indicated that each toxin interacts with its cognate antitoxin in vivo.
Autoregulation of the TA operon by the antitoxin
To investigate the autoregulation of the four TA operons, in vivo promoter activity assays were performed with E. coli WM3064 cells containing the corresponding reporter plasmids (Fig. 6A) . For the APJL 0660/0659 TA system, WM3064 cells harboring the pHGEI01-0660 plasmid showed an enzymatic activity significantly lower than that harboring pHGEI01-0660-0659 (P = 0.0001) (Fig. 6B) , suggesting that the antitoxin APJL 0660 increased the promoter activity. For the APJL 1287/1288 TA system, the enzymatic activity in cells carrying the pHGEI01-1287 plasmid was significantly higher than that in cells carrying pHGEI01- 1287-1288 (P = 0.0495) (Fig. 6C) , indicating that the antitoxin APJL 1287 repressed the promoter activity. For these two TA systems, the TA complex had no significant effect on the promoter activity ( Fig. 6B and C) . For the APJL 1766/1767 TA system, the promoter activity was repressed by the antitoxin, but enhanced by the TA complex (Fig. 6D) , while for the APJL 1865/1864 TA system, both the antitoxin and TA complex increased the promoter activity (Fig. 6E) . Furthermore, for the four TA systems, each toxin inhibited the autoregulatory effect of its cognate antitoxin ( Fig. 6B-E) . Taken together, these results suggested that the antitoxin could autoregulate either positively or negatively the TA operon transcription. Prevalence of the four TA systems in various serovars of Actinobacillus pleuropneumoniae PCR assays were performed to detect the prevalence of the four TA systems in serovars 1-14 of A. pleuropneumoniae. The APJL 0660/0659 TA system is present in serovars 3, 4, 5, 7, 8, 12 and 13 of A. pleuropneumoniae, while the other three TA systems are present in all detected reference strains (Supplementary Fig. S1 , Supporting Information). BlastN searches of the four complete genomes of A. pleuropneumoniae available in the NCBI database (as of 22 March 2017) confirmed the presence of the four TA systems in serovars 3, 5, 7 and 8 of A. pleuropneumoniae (Supplementary Table S3 , Supporting Information).
DISCUSSION
TA systems are widely distributed in bacteria and archaea and have attracted an increasing concern in recent years. Currently, these modules have been identified in numerous bacteria, including some clinical pathogens (Fernandez-Garcia et al. 2016; Lee and Lee 2016) . In uropathogenic Escherichia coli, TA systems play an important role in niche-specific colonization and stress resistance (Norton and Mulvey 2012) . Two TA systems (SezAT and yefM-yoeB) have been described in Streptococcus suis, and SezAT promotes the maintenance of the SsPI-1 pathogenicity island (Zheng et al. 2015; Yao et al. 2015b) . Genomic analysis of Mycobacterium tuberculosis H37Rv revealed the presence of a large number of TA systems (Sala, Bordes and Genevaux 2014) , several of which have been characterized (Korch, Contreras and ClarkCurtiss 2009; Miallau et al. 2009; Ramage, Connolly and Cox 2009; Han et al. 2010; Korch et al. 2015; Lee et al. 2015; Lu et al. 2016) . TA systems have also been well studied in S. pneumoniae (Nieto et al. 2006; Khoo et al. 2007; Chan et al. 2011 Chan et al. , 2014 Moreno-Cordoba et al. 2012; Chan and Espinosa 2016) , Vibrio cholerae (Budde et al. 2007; Hadzi et al. 2013 Hadzi et al. , 2015 Iqbal et al. 2015) and Staphylococcus aureus (Donegan and Cheung 2009; Donegan et al. 2010; Williams et al. 2011; Bukowski et al. 2013; Schuster and Bertram 2016) .
In this study, we demonstrated that four loci of A. pleuropneumoniae function as type II TA systems. The evidences are as follows: (i) each TA locus is encoded by an operon consisting of two small genes that are overlapped or separated by a few nucleotides; (ii) each toxin is toxic to E. coli, as overexpression of it inhibits bacterial growth and reduces cell viability; (iii) the toxicity of each toxin could be neutralized by its cognate antitoxin; (iv) each toxin and its cognate antitoxin form a complex; (v) antitoxin could regulate the promoter activity. These observations fit the common features of a typical type II TA system (Yamaguchi, Park and Inouye 2011) . To the best of The APJL 1865/1864 TA system. Escherichia coli WM3064 cells harboring the corresponding reporter plasmids were collected at the mid-exponential phase and tested for β-galactosidase activity. The data shown are means ± standard deviations of three independent experiments. Statistical analyses were performed using the one-tailed unpaired t test. our knowledge, this study is the first description of TA systems in Actinobacillus.
Our study started from bioinformatics prediction of type II TA systems. To yield broadly reliable TA candidates, rigorous screening of these modules was conducted, and seven putative type II TA systems were picked for further study. RT-PCR analysis revealed that for the seven putative TA systems, the toxin and antitoxin genes are co-transcribed, consistent with the results for previously identified type II TA modules (Khoo et al. 2007; Zheng et al. 2015; Li et al. 2016a) . Escherichia coli has been widely used for verification of TA systems due to its abundant conditional expression systems (Ning et al. 2013a) . We thus investigated the toxic and antitoxic effects of the putative TA components in E. coli. The expression of APJL 1376 only slightly attenuated bacterial growth, whereas the expression of APJL 1220/1219 did not result in normal growth. These results suggested that the APJL 1376/1375 and APJL 1220/1219 loci may not work as TA systems. We failed to construct the pBADhisA-1756-1757 plasmid after several attempts. Therefore, the APJL 1756/1757 locus was not included in further study. Pulldown experiments have been widely used to examine the interaction between the toxin and antitoxin pairs (Khoo et al. 2007; Ning et al. 2013a,b; Yao et al. 2015a; Chan and Espinosa 2016) . Through pull-down experiments, we showed that each toxin and its cognate antitoxin form a complex in vivo. Furthermore, promoter activity assays demonstrated that each antitoxin autoregulates the TA operon, positively or negatively. In contrast to the VapC toxin in Streptomyces sp. that works with its cognate antitoxin to repress promoter activity (Guo et al. 2016) , each toxin identified here inhibited the autoregulatory effect of its cognate antitoxin.
The APJL 1287/1288, APJL 1766/1767 and APJL 1865/1864 loci were detected in all 14 serovars investigated, indicating that these TA systems are well conserved in A. pleuropneumoniae, whereas the APJL 0660/0659 was only detected in seven serovars. Three of the four TA systems (APJL 0660/0659, APJL 1766/1767 and APJL 1865/1864) are classified into the vapBC family, and the other one (APJL 1287/1288) belongs to the relBE/parDE family. The vapBC family TA systems have been described in many bacterial species, such as Leptospira interrogans (Zhang et al. 2004) , Mycobacterium tuberculosis (Miallau et al. 2009; Winther et al. 2016) and Thermus thermophilus (Fan, Hoshino and Nakamura 2017) . The VapC proteins are endoribonucleases that cleave RNAs (Lopes et al. 2014; Winther et al. 2016; Fan, Hoshino and Nakamura 2017) . In Sulfolobus solfataricus, several vapBC loci are involved in thermal stress response (Cooper et al. 2009 ). The APJL 1287/1288 locus is homologous to the yefM-yoeB TA system. This module is one of the well-characterized TA systems. In E. coli and S. aureus, the YoeB toxin inhibits translation initiation (Yoshizumi et al. 2009; Zhang and Inouye 2009) . In S. suis, the yefM-yoeB locus is an active TA system but does not appear to contribute to virulence (Zheng et al. 2015) . On the other hand, in uropathogenic E. coli, this TA system promotes colonization of the bladder (Norton and Mulvey 2012) . The mechanism of action of these toxins and roles of the four type II TA systems in A. pleuropneumoniae will be explored in future studies. Development of novel antibiotics based on these TA systems could also be promising.
In conclusion, this study clearly demonstrated that four loci encode type II TA systems in A. pleuropneumoniae, with three of the four systems well conserved among different serovars. Overproduction of each toxin in E. coli led to growth inhibition that was counteracted by the presence of its cognate antitoxin. Each toxin and its cognate antitoxin were shown to form a complex in vivo, and each antitoxin was shown to autoregulate expression of its TA operon.
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